INGRES CORPORATION – Trademark Portfolio
Entity Type: 03
INGRES CORPORATION holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 15 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ACTIAN, INGRES, and OPENROAD. The owner is based in ALAMEDA, CA.
1080 MARINA VILLAGE PARKWAY
ALAMEDA, CA 94501
Showing of trademarks Trademarks
Trademark Classifications
INGRES CORPORATION's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does INGRES CORPORATION have?
INGRES CORPORATION has 18 U.S. trademarks filed with the USPTO. Of these, 3 registered, 8 abandoned, 6 cancelled.
What trademark classes does INGRES CORPORATION file in?
INGRES CORPORATION files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are INGRES CORPORATION's most well-known trademarks?
INGRES CORPORATION's registered trademark portfolio includes well-known marks such as ACTIAN, INGRES, and OPENROAD. These are among 3 currently registered trademarks in the portfolio.
What is INGRES CORPORATION's trademark registration success rate?
INGRES CORPORATION has a 18% trademark registration rate, with 3 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.